Karl Stefic

Université de Tours

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Boris Julg

UNITED STATES

View details

Marta Pingarilho

PORTUGAL

View details

Wen-Han Yu

Bill & Melinda Gates Medical Research Institute

UNITED STATES

View details

Anne-Genevieve Marcelin

Professor of Virology

Sorbonne Université Faculté de Médecine

FRANCE

View details

Honorine Fenaux

Université de Lorraine

FRANCE

View details

Chuangqi Wang

Assistant Professor (Research)

University of Colorado Boulder

UNITED STATES

View details

Leslie Guillon-Grammatico

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Karl Stefic

Research Interests

Explore related searches

Contact this professor

Articles (10)

Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study

Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe

Landscape of HIV neutralization susceptibilities across tissue reservoirs.

ELISA-Based Analysis Reveals an Anti-SARS-CoV-2 Protein Immune Response Profile Associated with Disease Severity

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.

Atypical New Lav Blot I (HIV-1 Western blot) profile with loss of antibodies to gp120, gp41 and polymerase in a HIV-1 subtype A infected patient at AIDS stage

Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells.

[Monoclonal antibodies for prevention or treatment of HIV-1 infection: what next after the first clinical trials?]

[Protection against HIV-1 infection: "It's the neutralizing antibody, stupid!"]

Collaborators (7)

Boris Julg

Marta Pingarilho

Wen-Han Yu

Anne-Genevieve Marcelin

Honorine Fenaux

Chuangqi Wang

Leslie Guillon-Grammatico

Make your next move.